ANN SWEET: Open Payments
NPI 1033141957 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 54 payments from 11 companies in 2025. Trend: 2023 $1,222 · 2024 $1,270 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $468 |
| ABBVIE INC. | 11 | $256 |
| UCB, Inc. | 6 | $163 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Fresenius Kabi USA, LLC | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| SOBI, INC | 2 | $40 |
| PFIZER INC. | 2 | $32 |
| Genentech USA, Inc. | 1 | $32 |
Products named: RINVOQ, EVENITY, Bimzelx, UPLIZNA, COSENTYX, SKYRIZI, BENLYSTA, STRENSIQ.
Industry payments across NY — which companies pay providers there.
